Superior efficacy of tumor cell vaccines grown in physiologic oxygen - Wikidata - wikimedia - TriplyDB

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

http://www.wikidata.org/entity/Q34468716

about

Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Effects of oxygen on the antigenic landscape of prostate cancer cells.Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring Increasing the efficacy of tumor cell vaccines by enhancing cross priming Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant.Dendritic cells in cancer immunotherapy clinical trials: are we making progress?Vaccine-based immunotherapeutic approaches to gliomas and beyond.Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.Oxygen is a master regulator of the immunogenicity of primary human glioma cells.Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies.9-Amino acridine pharmacokinetics, brain distribution, and in vitro/in vivo efficacy against malignant glioma.

P2860

Q27012618-07CBE2A7-E4D7-4589-92F8-E318251E425B Q33606132-DC68E3BC-5A71-4F6C-99E1-21168D0C3325 Q34976095-596BD8E6-E5F7-463D-80A4-FE56D52DB670 Q35799695-E227B8EA-AF24-4C9E-AD4B-130CE9144C90 Q35845496-091FE804-F2CF-46EE-90C2-2E5000AB161F Q36048767-9671807F-C9E8-454D-949A-CBF352A7CD22 Q36288105-1B342397-FA94-4F27-8D7A-20E86B667436 Q36514324-52400116-08DA-44A2-A72D-221E8C6E0C4E Q36584178-732E4B37-6BE1-483F-AD45-BB0FA2D6BE06 Q37389096-9EF0A93E-67F7-482D-B101-23EED730A093 Q38789860-1285372B-D093-44B5-9270-E3CFC554D7F7 Q38925761-F082B274-8AF6-4157-9255-DB070CAD6C35 Q39316966-F991C644-C600-402C-AFE4-12ABF8D0D52D Q39532047-9415A34A-0BF6-4839-8320-4F6BBDB368F2 Q42177993-D0655BC3-98FC-4286-9892-57F8371A0FC4 Q42639856-51F5F96E-B706-4E83-AD82-E673FC3576EB Q44600407-16F2B5DC-C3D6-44C5-AF9E-2BA3CBB2B69B Q48622942-C965D1E5-BE68-4673-A3DB-0DAA0C17CDBD

P2860

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

http://www.wikidata.org/entity/Q34468716

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@ast

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@en

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@nl

type

label

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@ast

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@en

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@nl

prefLabel

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@ast

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@en

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@nl

P1433

Q34468716-FFDB23A8-6B67-46A3-AF48-97246D0036B3

P1476

Q34468716-10222FBC-A115-473C-91D7-B2F8E4D228F8

P2093

Q34468716-23964F52-A463-41C2-B3EB-2EFC5AE7E84B

Q34468716-293DDB76-0781-496B-9B97-FB55A5206B2D

Q34468716-2E6F7AB4-A4E8-4C50-8346-54FD948158E1

Q34468716-35E04E3A-41CF-489B-83D8-E54EBBA46E5A

Q34468716-5461C4A6-8B64-4C10-A98D-E93F76EF31B5

Q34468716-7F1A96F8-2FFA-4052-9360-DBDC09829452

Q34468716-857103DF-BD8E-46EC-95B2-77B13EA3B09C

Q34468716-91BCBEB0-52CD-408A-A31C-387D6418BCE2

Q34468716-BD6FFD85-8114-46B9-BD40-559A2B943A70

Q34468716-DD52D112-CA02-4163-9A7F-3BDFC75CE677

P2860

Q34468716-33552A90-EF19-48DE-B2D2-080588333593

Q34468716-35D21E9F-6F04-46D9-A695-8C8368855742

Q34468716-4EEA54C5-7D3D-40D7-A4E3-AFB2A44435D9

Q34468716-4F13DE1B-3500-4BFA-8D94-93FC93F3B835

Q34468716-5127C371-ABE6-4ED0-955F-1129B4F22AFD

Q34468716-697DB8D3-D80F-4E3A-B0B5-3BC229F3BEAB

Q34468716-6AE9BDCB-D166-4C9E-9AB6-2A5BC8D472CB

Q34468716-6E70F098-DDEF-41E5-8060-BE42CB79F971

Q34468716-751AFCFD-C1DA-46A6-B933-F826D6955B41

Q34468716-9DF85B3B-3B92-4557-B025-D39BAF9BC73B

P304

Q34468716-A7DFD687-D3C1-49F6-8369-04C0C026A1F2

P31

Q34468716-9DB3401B-FA35-4C3C-BCC1-DA76BD63EADD

P356

Q34468716-918E913B-4048-4D9A-A1AB-295582F473C5

P407

Q34468716-9BCB62A3-2EE4-4880-8774-8CD223582602

P433

Q34468716-5CBE5C78-3CD8-443C-9E69-6D2F0899DFB4

P478

Q34468716-331C0358-20EB-4CCE-828B-953DCD65ED94

P50

Q34468716-61617225-7F50-4B85-8C13-810CA9FB3C76

P577

Q34468716-F6CB4CCB-C4F7-4C11-8A76-60125AE97B17

P5875

Q34468716-104BDEFF-08FC-4843-8479-A094D6ECAE85

P698

Q34468716-1B49B4D2-D728-4DEF-B374-A2D7593AFC2E

P932

Q34468716-A74B3864-266F-413F-A871-51747441E144

P356

1078-0432.CCR-10-1572

P1433

Clinical Cancer Research

P1476

Superior efficacy of tumor cell vaccines grown in physiologic oxygen

@en

P2093

Brian M Andersen

http://www.w3.org/2001/XMLSchema#string

Charlie Seiler

http://www.w3.org/2001/XMLSchema#string

Colleen L Forster

http://www.w3.org/2001/XMLSchema#string

David M Zellmer

http://www.w3.org/2001/XMLSchema#string

Flavia E Popescu

http://www.w3.org/2001/XMLSchema#string

John R Ohlfest

http://www.w3.org/2001/XMLSchema#string

Karen S SantaCruz

http://www.w3.org/2001/XMLSchema#string

Michael R Olin

http://www.w3.org/2001/XMLSchema#string

Patrick T Grogan

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia is important in the biology and aggression of human glial brain tumors.

Modulation of adaptive immunity with Toll-like receptors

Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

Therapeutic potential of Toll-like receptor 9 activation.

Hypoxia and adaptive landscapes in the evolution of carcinogenesis.

Development of TLR9 agonists for cancer therapy

Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?

Cell based cancer vaccines: regulatory and commercial development.

P304

4800-4808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-10-1572

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46393248

http://www.w3.org/2001/XMLSchema#string

P698

20858839

http://www.w3.org/2001/XMLSchema#string

P932

3016438

http://www.w3.org/2001/XMLSchema#string